McGuire Investment Group, LLC Buys Catalent Inc, Medpace Holdings Inc, iShares Core S&P Total U.S. Stock Market, Sells SPDR Bloomberg Barclays 1-3 Month T-Bill, SPDR Bloomberg Barclays Investment Grade Floating , iShares Floating Rate Bond

• New Purchases: ITOT, VGT, BSX, CDMO, RGLS,
• Added Positions: CTLT, XBI, MEDP, QCOM, IJR, XLNX, ADI, XLV, VB, XLF, XLK, IHI, UPS, SMH, GOOGL, XLI, HACK, IVV, DIS, SGMO, ASML,
• Reduced Positions: VO, CVS, IVZ, FDX, IYT, IAI, COST, MMM, EEM, IBB, SQ, VOO, QQEW, MDY, IWM, NVDA, GS, CSCO, AMD, IEMG, SNY,
• Sold Out: BIL, FLRN, FLOT, VWO, CHIQ, CQQQ, VTI, SLB, STT, KBE, PSI,

For the details of McGuire Investment Group, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/mcguire+investment+group%2C+llc/current-portfolio/portfolio

1. Xilinx Inc (XLNX) - 174,958 shares, 5.85% of the total portfolio. Shares added by 1.17%
2. Qualcomm Inc (QCOM) - 170,599 shares, 4.95% of the total portfolio. Shares added by 1.35%
3. Apple Inc (AAPL) - 43,421 shares, 4.74% of the total portfolio. Shares reduced by 0.81%
4. Cboe Global Markets Inc (CBOE) - 112,470 shares, 4.31% of the total portfolio. Shares reduced by 0.85%
5. Stryker Corp (SYK) - 59,551 shares, 4.26% of the total portfolio. Shares added by 0.78%

McGuire Investment Group, LLC initiated holding in iShares Core S&P Total U.S. Stock Market. The purchase prices were between $49.42 and $76.04, with an estimated average price of $68.3. The stock is now traded at around $55.06. The impact to a portfolio due to this purchase was 0.13%. The holding were 5,274 shares as of .

McGuire Investment Group, LLC initiated holding in Vanguard Information Tech. The purchase prices were between $185.49 and $273.21, with an estimated average price of $244.1. The stock is now traded at around $203.37. The impact to a portfolio due to this purchase was 0.1%. The holding were 1,139 shares as of .

McGuire Investment Group, LLC initiated holding in Boston Scientific Corp. The purchase prices were between $25.83 and $45.71, with an estimated average price of $39.29. The stock is now traded at around $30.81. The impact to a portfolio due to this purchase was 0.09%. The holding were 6,425 shares as of .

McGuire Investment Group, LLC initiated holding in Avid Bioservices Inc. The purchase prices were between $3.15 and $7.67, with an estimated average price of $6.1. The stock is now traded at around $4.67. The impact to a portfolio due to this purchase was 0.03%. The holding were 13,300 shares as of .

McGuire Investment Group, LLC initiated holding in Regulus Therapeutics Inc. The purchase prices were between $0.44 and $1.51, with an estimated average price of $0.88. The stock is now traded at around $0.47. The impact to a portfolio due to this purchase was less than 0.01%. The holding were 19,000 shares as of .

McGuire Investment Group, LLC added to a holding in Catalent Inc by 1198.66%. The purchase prices were between $36.95 and $62.95, with an estimated average price of $54.82. The stock is now traded at around $48.97. The impact to a portfolio due to this purchase was 2.1%. The holding were 102,140 shares as of .

McGuire Investment Group, LLC added to a holding in Medpace Holdings Inc by 30.09%. The purchase prices were between $61.71 and $101.95, with an estimated average price of $87. The stock is now traded at around $69.77. The impact to a portfolio due to this purchase was 0.37%. The holding were 50,272 shares as of .

McGuire Investment Group, LLC added to a holding in Vanguard Small-Cap by 33.39%. The purchase prices were between $98.45 and $170.48, with an estimated average price of $151.89. The stock is now traded at around $107.95. The impact to a portfolio due to this purchase was 0.04%. The holding were 3,164 shares as of .

McGuire Investment Group, LLC sold out a holding in SPDR Bloomberg Barclays 1-3 Month T-Bill. The sale prices were between $91.25 and $91.66, with an estimated average price of $91.43.

McGuire Investment Group, LLC sold out a holding in SPDR Bloomberg Barclays Investment Grade Floating . The sale prices were between $26.27 and $30.78, with an estimated average price of $30.14.

McGuire Investment Group, LLC sold out a holding in iShares Floating Rate Bond. The sale prices were between $44.1 and $51, with an estimated average price of $49.94.

McGuire Investment Group, LLC sold out a holding in Vanguard FTSE Emerging Markets. The sale prices were between $30.46 and $45.91, with an estimated average price of $41.1.

McGuire Investment Group, LLC sold out a holding in Global X MSCI China Consumer Discretionary. The sale prices were between $14.62 and $20.06, with an estimated average price of $17.95.

McGuire Investment Group, LLC sold out a holding in Invesco China Technology. The sale prices were between $44.32 and $58.93, with an estimated average price of $53.74.

McGuire Investment Group, LLC reduced to a holding in Vanguard Mid-Cap by 84.34%. The sale prices were between $112.37 and $186.27, with an estimated average price of $167.2. The stock is now traded at around $125.23. The impact to a portfolio due to this sale was -0.82%. McGuire Investment Group, LLC still held 2,736 shares as of .

McGuire Investment Group, LLC reduced to a holding in CVS Health Corp by 53.31%. The sale prices were between $52.3 and $76.05, with an estimated average price of $67.09. The stock is now traded at around $54.78. The impact to a portfolio due to this sale was -0.58%. McGuire Investment Group, LLC still held 21,655 shares as of .